Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
Fissolo N, Benkert P, Sastre-Garriga J, Mongay-Ochoa N, Vilaseca-Jolonch A, Llufriu S, Blanco Y, Hegen H, Berek K, Perez-Miralles F, Rejdak K, Villar LM, Monreal E, Alvarez-Lafuente R, Soylu OK, Abdelhak A, Bachhuber F, Tumani H, Martínez-Yélamos S, Sánchez-López AJ, García-Merino A, Gutiérrez L, Castillo-Trivino T, Lycke J, Rosenstein I, Furlan R, Filippi M, Téllez N, Ramió-Torrentà L, Lünemann JD, Wiendl H, Eichau S, Khalil M, Kuhle J, Montalban X, Comabella M. Fissolo N, et al. Among authors: tellez n. J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):410-418. doi: 10.1136/jnnp-2023-332251. J Neurol Neurosurg Psychiatry. 2024. PMID: 37940409
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
Tintoré M, Rovira A, Río J, Tur C, Pelayo R, Nos C, Téllez N, Perkal H, Comabella M, Sastre-Garriga J, Montalban X. Tintoré M, et al. Among authors: tellez n. Neurology. 2008 Mar 25;70(13 Pt 2):1079-83. doi: 10.1212/01.wnl.0000280576.73609.c6. Epub 2007 Sep 19. Neurology. 2008. PMID: 17881717
Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.
Comabella M, Julià E, Tintoré M, Brieva L, Téllez N, Río J, López C, Rovira A, Montalban X. Comabella M, et al. Among authors: tellez n. J Neurol. 2008 Aug;255(8):1136-41. doi: 10.1007/s00415-008-0855-1. Epub 2008 May 20. J Neurol. 2008. PMID: 18484235 Clinical Trial.
Clinical features of CIS of the brainstem/cerebellum of the kind seen in MS.
Sastre-Garriga J, Tintoré M, Nos C, Tur C, Río J, Téllez N, Castilló J, Horga A, Perkal H, Comabella M, Rovira A, Montalban X. Sastre-Garriga J, et al. Among authors: tellez n. J Neurol. 2010 May;257(5):742-6. doi: 10.1007/s00415-009-5403-0. Epub 2009 Nov 28. J Neurol. 2010. PMID: 19946780
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
Montalban X, Sastre-Garriga J, Filippi M, Khaleeli Z, Téllez N, Vellinga MM, Tur C, Brochet B, Barkhof F, Rovaris M, Miller DH, Polman CH, Rovira A, Thompson AJ. Montalban X, et al. Among authors: tellez n. Mult Scler. 2009 Dec;15(12):1459-65. doi: 10.1177/1352458509348422. Epub 2009 Dec 7. Mult Scler. 2009. PMID: 19995843
96 results